SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

74,781.76 -120.83
( -0.16%)

Global Indices

Nasdaq

52,596.82 511.72
(0.98%)

Dow Jones

7,678.62 65.92
(0.87%)

Hang Seng

63,517.44 -493.90
(-0.77%)

Nikkei 225

10,650.44 41.52
(0.39%)

Forex

USD-INR

95.45 0.39
(0.41%)

EUR-INR

110.95 0.35
(0.32%)

GBP-INR

129.16 0.36
(0.28%)

JPY-INR

0.62 0.00
(0.09%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Strides Pharma Science Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

532531

INE939A01011

356.2353295

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

STAR

60.7

10932.61

EPS(TTM)

Face Value()

Div & Yield %

19.54

0.42

Back

Kalind consolidated net profit rises 175.38% in the June 2026 quarter

Jul 31,2026

Net profit of Kalind rose 175.38% to Rs 14.65 crore in the quarter ended June 2026 as against Rs 5.32 crore during the previous quarter ended June 2025. Sales rose 157.79% to Rs 35.06 crore in the quarter ended June 2026 as against Rs 13.60 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	35.06	13.60	158
OPM %	62.75	42.06	-
PBDT	22.28	6.26	256
PBT	18.61	6.26	197
NP	14.65	5.32	175

74,781.76 -120.83 ( -0.16%)

52,596.82 511.72 (0.98%)

7,678.62 65.92 (0.87%)

63,517.44 -493.90 (-0.77%)

10,650.44 41.52 (0.39%)

95.45 0.39 (0.41%)

110.95 0.35 (0.32%)

129.16 0.36 (0.28%)

0.62 0.00 (0.09%)